https://www.ema.europa.eu/en/medicines/human/EPAR/waylivra 2019 false false false United Kingdom French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation drug approval europe Volanesorsen Volanesorsen orphan drug production familial hyperchylomicronemia syndrome injections, subcutaneous apolipoprotein c-iii product surveillance, postmarketing adult aged drug interactions pregnancy breast feeding drug evaluation, preclinical volanesorsen ISIS 304801 ISIS 304801 hyperlipoproteinemia type i oligonucleotides oligonucleotides
ATC code(s)